Retail

CVS suspends sales of Zantac brand and generic heartburn drug during safety review

Key Points
  • CVS Health said it will discontinue sales the popular Zantac heartburn treatment and its own generic ranitidine products after traces of a known carcinogen were found in some of the products by the FDA.
  • CVS said the move was taken out of caution while the FDA continues to review if low levels of NDMA in ranitidine — the active ingredient in Zantac — poses a health risk to patients.
Zantac tablets
Source: Wikipedia

CVS Health said on Saturday it will discontinue sales the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products by the U.S. Food and Drug Administration.

The FDA said earlier this month that some of the pills contained small amounts N-nitrosodimethylamine (NDMA), which has also been found in some widely used blood pressure medicines, leading to shortages of those drugs.

CVS said the move to suspend sales of the over-the-counter heartburn drug was taken out of caution while the FDA continues to review if low levels of NDMA in ranitidine — the active ingredient in Zantac — poses a health risk to patients.

"Zantac brand products and CVS brand ranitidine products have not been recalled, and the FDA is not recommending that patients stop taking ranitidine at this time," CVS said in a statement.

Novartis' Sandoz unit said last week it was halting distribution of Zantac in all its markets, including the United States and Canada, following safety review of the drug by U.S. and European drug regulators.

WATCH: Health care analyst gives top stock picks ahead of 2020 elections

VIDEO5:4205:42
Health care analyst gives her top stock picks ahead of the 2020 elections
Next Article
Key Points
  • Apparel retailer Forever 21 said Sunday night it is filing for Chapter 11 bankruptcy protection.
  • The fast-fashion retailer is obtained $350 million in financing to support it through bankruptcy.
  • Forever 21 has requested approval to close up to 178 U.S. stores, a spokesperson says.